References
- O'Neil J, Powell L. Clinical aspects of hemochromatosis. Semin Liver Dis 2005; 25: 381–391.
- Connor JR, Menzies SL. Relationship of iron to oligodendrocytes and myelination. Glia 1996; 17: 83–93.
- Beard JL, Chen Q, Connor J, Jones BC. Altered monamine metabolism in caudate-putamen of iron-deficient rats Pharmacol Biochem Behav 1994; 48: 621–624.
- Li D. Effects of iron deficiency on iron distribution and gamma-aminobutyric acid (GABA) metabolism in young rat brain tissues. Hokkaido Igaku Zasshi 1998; 73: 215–225.
- Huang X, Atwood CS, Hartshorn MA et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999; 38: 7609–7616.
- Ong WY, Farooqui AA. Iron, neuroinflammation, and Alzheimer's disease J Alzheimers Dis 2005; 8: 183-200, discussion 209-215.
- Li JL, Okada S, Hamazaki S, Ebina Y Midorikawa O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 1987; 47: 1867–1869.
- Awai M, Narasaki M, Yamanoi Y Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol 1979; 95: 663-673.
- Kawabata T, Awai M, Kohno M. Generation of active oxygen species by iron nitrilotriacetate (Fe-NTA). Acta Med Okayama 1986; 40: 163–173.
- Liu M, Okada S, Kawabata T. Radical-promoting ‘free’ iron level in the serum of rats treated with ferric nitrilotriacetate: comparison with other iron chelate complexes. Acta Med Okayama 1991; 45: 401–408.
- Langmead CJ, Austin NE, Branch CL et al. Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1. Br J Pharmacol 2008; 154: 1104–1115.
- Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain. I. The disposition of PH]norepinephrine, pli]clopamine and rH]dopa in various regions of the brain. J Neurochem 1966; 13: 655–669.
- Hill JM, Switzer 3rd RC. The regional distribution and cellular localization of iron in the rat brain. Neuroscience 1984; 11: 595–603.
- Morris CM, Kerwin JM, Edwardson JA. Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration 1994; 3: 267–275.
- Berlin D, Chong G, Chertkow H, Bergman H, Phillips NA, Schipper HM. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol Aging 2004; 25: 465–474.
- Kondo Y, Ogawa N, Asanuma M, Ota Z, Mori A. Regional differences in late-onset iron deposition, ferritin, transferrin, astrocyte proliferation, and microglial activation after transient forebrain ischemia in rat brain. J Cereb Blood Flow Metab 1995; 15: 216–226.
- Wang XS, Ong WY, Connor JR. Increase in ferric and ferrous iron in the rat hippocampus with time after kainate-induced excitotoxic injury. Exp Brain Res 2002; 143: 137–148.
- Maeda S, Nakatsuka I, Hayahi Y, Higuchi H, Shimada M, Miyawaki T. Heme oxygenase-1 induction in the brain during lipopolysaccharide-induced acute inflammation. Neuropsychiatr Dis Treat 2008; 4: 663–667.
- Ryter SW, Choi AM. Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress Antiaxid Redox Signal 2002; 4: 625-632.
- Yamaoka K, Mori S, Nomura T et al. Elevation of antioxidant potency in mice brain by low-dose X-ray irradiation and its effect on Fe-NTA-induced brain damage. Physiol Chem Phys Med NMR 2002; 34: 119–132.
- White P, Hiley CR, Goodhardt MJ et al. Neocortical cholinergic neurons in elderly people Lancet 1977; 1: 668–671.
- Mancama D, Arranz MJ, Landau S, Kerwin R. Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2003; 119B: 2–6.
- Okada S. Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals Pathol Int 1996; 46: 311-332.